ABSTRACT Ventricular action potentials and longitudinal conduction times over short distances of epicardium were recorded in isolated rabbit hearts. Global ischemia produced a progressive decrease of resting membrane potential, depression of action potentials, and conduction slowing to approximately 50% of control values over 8 to 10 min. Verapamil (2 x 10-6M) markedly attenuated ischemiainduced conduction slowing in association with less depression of maximum upstroke velocity (Vmax) and slightly less change in resting membrane potential. 
KABELL the effect of calcium-channel activation state on factors related to impulse propagation during acute ischemia. These include the magnitude of ischemia-induced depolarization of resting membrane potential, alteration in membrane responsiveness, and alteration in the relation of conduction velocity to maximum upstroke velocity (Vmax)
Methods
Experimental preparation. White New Zealand rabbits (6 to 8 kg) were premedicated with ketamine (25 mg/kg). The animals were killed by cervical dislocation and the hearts were rapidly removed, rinsed with iced Tyrode's solution, and perfused via an aortic cannula at constant flow (3 to 5 ml/minlg) in a modified Langendorf preparation (figure 1). The Tyrode solution had the following composition: NaCl 137 mM, KCL 5.5 mM, MgCl2 1.5 mM, CaCl2 2.0 mM, NaHCO3 11.9 mM, NaH2PO4 0.42 mM, glucose 11 mM, pyruyate 2.0 mM, EDTA 0.57 mM, and ascorbic acid 1.42 ,gM. The solution was gassed with 95% 02, 5% CO2 (95% N2, 5% CO2 during the ischemic period); pH was 7.40. The mitral valve and pulmonary artery were cut and the sinoatrial node and a portion of the right atrium were removed. The heart was submerged in a jacketed 4 X 6 X 4 cm tissue bath and positioned with the anterior left ventricle up. Temperature was maintained at 350 C by a thermostatically controlled pump.
With a micromanipulator, pacing and recording electrodes were positioned in a linear array on the anterior surface of the left ventricle parallel to fiber orientation as determined visually through a dissecting microscope. The pacing electrode was constructed from two Teflon-coated stainless steel wires (0.003 inch diameter) with an intraelectrode distance of 0.2 mm. Stimuli were delivered by a Grass S-88 stimulator and SIUSA isolation unit (4 msec duration, two times diastolic threshold). Activation times were measured with unipolar electrograms recorded by Teflon-coated tungsten wire (0.002 inch diameter) electrodes and amplified and displayed with use of Tektronix 5A26 A-C coupled differential amplifier and a 5113 dual-beam storage oscilloscope. Injury potentials, which were frequently noted initially, subsided after the first few minutes of equilibration. Electrode positions were verified and interelectrode distances were measured by ocular micrometer before and after each episode of ischemia. Interelectrode distance ranged from 1.5 to 2.1 mm between pacing and proximal recording electrodes and 1.5 to 4.0 mm between proximal and distal recording electrodes. Apparent conduction velocity (0) was calculated by the equation: 0 = d/At, where At is the difference in activation time and d is distance between proximal and distal electrodes.
Transmembrane potentials were recorded with flexibly mounted microelectrodes.22 Tips from glass micropipettes filled with 3M KCl were suspended from fine tungsten wire (0.001 in), with Ag-AgCl wires serving as reversible half cells. Electrode resistance ranged from 20 to 40 MQl. Signals were fed to a high-impedance WPI750 preamplifier and dV/dt was obtained with an electronic differentiator. Calibration was achieved with a ramp generator and response was linear from 5 to 200 V/sec. Both transmembrane potential and its first derivative were amplified with Tektronix 5A26 preamplifiers and displayed on a Tektronix 5113 dual-beam storage oscilloscope simultaneously with extracellular electrograms. Records were obtained on Polaroid film and with a Gould 2200S strip-chart recorder.
In vigorously beating perfused hearts, stable recordings of transmembrane potentials were easily obtainable, but generally microelectrode distal electrode temp.
A~~~~~~~u FIGURE 1. Experimental preparation. The isolated rabbit heart is positioned horizontally with the anterior left ventricle up and perfused via an aortic cannula. Extracellular stimulating and recording electrodes are positioned in a linear array parallel to fiber orientation. A flexibly mounted microelectrode was used to make multiple impalements between proximal and distal recording sites (see text for details).
only for brief intervals ranging from several seconds to a few minutes. However, after the first few minutes of ischemia it was often possible to hold impalements for several minutes. 
Results
Electrophysiologic changes during global ischemia.
Hearts contracted vigorously during normal perfusion. However, contractions quickly diminished and hearts became mechanically quiescent during the first minute of ischemia. In a few instances, recordings were made from a single impalement maintained under control conditions and throughout a 10 min period of global ischemia. Tracings from one of these continuous recordings are illustrated in figure 2 and are representative of data obtained with multiple serial impalements. There was a progressive loss of resting membrane potential, shortening of action potential duration, and a decrease in action potential amplitude. The rate of rise of the action potential also progressively decreased and the difference in activation times between proximal and distal electrograms was increased as conduction slowed. These changes are illustrated in figure 3 .
When the duration of global ischemia was brief (10 min or less), action potential variables and conduction times rapidly returned to control values after reperfusion. This allowed multiple ischemic episodes to be studied in each preparation. As illustrated in table 1, the electrophysiologic changes induced by global ischemia were quite reproducible in three serial periods of global ischemia when a 30 min recovery period of perfusion was allowed between each period of ischemia. At 8 to 10 min of ischemia, apparent conduction velocity decreased by approximately 50% and changes in all variables relative to control were statistically significant (p < .01). Ventricular arrhythmias were never observed either during ischemia or reperfusion.
Effect of verapamil. The effects of verapamil on ischemia-induced changes in conduction and action potential characteristics are summarized in table 2. During normal perfusion, verapamil (2 x 10 -6M) significantly decreased action potential duration but did not affect conduction, resting membrane potential, action potential amplitude, or Vmax. However, during ischemia there was considerably less slowing of conduction, slightly less depolarization, and a significant preservation of upstroke velocity. Action potential duration, which was decreased before ischemia, was slightly longer after 8 to [1] [2] However, in the present investigation no arrhythmias were observed either during ischemia or after reperfusion. This is possibly due to the fact that the duration of each ischemic period was brief (10 min or less) and ischemia was global rather than regional. One could speculate that heterogeneity of conduction, refractoriness, and/or resting potential was not sufficient to produce arrhythmias by reentry or other mechanisms. Calcium overload during ischemia or reperfusion, particularly in the presence of Bay K 8644, might favor the production of arrhythmias due to early afterdepolarizations and triggered activity. However, there was no evidence for this under the experimental conditions of this study. Apparent conduction velocity, which was calculated by dividing the distance between two closely positioned unipolar recording sites by the difference in conduction time, slowed to approximately 50% of control values over 8 to 10 min of global ischemia. This method assumes a constant linear pathway between recording electrodes. However, the actual pathway of propagation is unknown. Although detailed mapping of activation was not performed in this study, the method used probably yields a good estimate of the changes in mean conduction velocity for the following reasons: (1) Conduction times were measured over short distances (1.5 to 4.0 mm). (2) During ischemia, conduction times progressively prolonged in a continuous fashion, without abrupt changes in electrogram configuration. In those few instances when these findings were observed before 8 min of ischemia, the data were excluded from analysis because this was believed to be consistent with local conduction block and a change in the pathway of propagation. (3) Mapping studies by others have demonstrated homogeneous epicardial activation with elliptical isochrones29 and during the first few minutes of ischemia conduction slows in a continuous, uniform fashion before the appearance of local areas of block.30 (4) Values of apparent conduction velocity obtained in the present study were similar to those reported by others using either multiple epicardial electrodes31 or high-density mapping techniques.30
Efects of verapamil and Bay K 8644. Numerous experimental studies have demonstrated that calcium channel-blocking agents can prevent or delay conduction slowing and local conduction block induced by acute ischemia2, 8, 1921, 32 However, in a recent study by Kimura et al., 28 verapamil was reported to have no effect on conduction slowing in ischemic cat endocardium. In other studies, combined hypoxia, hyperkalemia, and acidosis simulating ischemia have been shown to produce more severe changes in subepicardium than subendocardium33 and Kimura et al.34 have previously demonstrated a marked protective effect of verapamil on conduction delay under these conditions in canine subepicardium. In a subsequent study in the isolated cat heart,35 these same authors confirmed that ischemia produces more severe electrophysiologic changes in subepicardium relative to subendocardium and that verapamil attenuates conduction slowing only in subepicardium. They also noted that although this effect was evident after 10 min of ischemia, after 20 min there was no significant difference from control.
Since the protective effect of calcium channelblocking agents appears to be largely independent of changes in factors that act to reduce the severity of ischemia such as increases in myocardial blood flow and afterload reduction, it has been suggested that calcium channel-blocking agents are acting directly to modify the electrophysiologic effects of ischemia. 8 The most plausible explanation for this is that these agents act by decreasing the amount of calcium entry into cells before and/or during ischemia.
Although intracellular calcium was not measured in the present study and verapamil is known to have many Vol. 77, No. 6, June 1988 actions other than its calcium channel-blocking properties, the fact that Bay K 8644, an agent that activates calcium channels, had an effect opposite that of verapamil and exacerbated ischemia-induced conduction slowing is consistent with this hypothesis. Furthermore, a diversity of other calcium channel-blocking agents, including diltiazem,20 21 nifedipine, and the inorganic ion Ni +,36 have been shown to attenuate subepicardial conduction slowing due to ischemia or simulated ischemic conditions. Intracellular calcium activity between contractions is normally low and controlled by energy-requiring processes such as sequestration in sarcoplasmic reticulum and mitochondria as well as exchange across the cell membrane. During ischemia, intracellular calcium tends to rise and limited energy supplies are used to maintain low intracellular calcium activity. If total intracellular calcium stores are high at the onset of ischemia or if calcium influx across the cell membrane from outside is relatively high during ischemia, then the metabolic expense of maintaining calcium homeostasis will be high. This will lead to a more rapid depletion of high-energy phosphates and since ATP is produced via glycolysis, intracellular pH will fall faster in settings in which calcium load is high. Agents that modulate calcium-channel activation could be acting before ischemia to affect the total intracellular calcium load at the onset of ischemia or during ischemia to affect additional calcium influx. 42 Although verapamil had a minor effect on ischemiainduced depolarization, the observed preservation of action potential upstroke velocity cannot be explained on this basis alone. As illustrated in figure 4 , verapamil altered membrane responsiveness such that at depolarized resting potentials during ischemia, Vmax was significantly greater in the presence of verapamil. Bay K 8644 had the opposite effect such that at depolarized resting potentials, Vmax was less than control. In this regard, the effect of verapamil is in agreement with the findings of Kimura et al. ' 3 who reported that although verapamil did not alter resting membrane potential under simulated ischemic conditions, there was a significant improvement in Vmax. El-Sherif and Lazzara43 studied dog hearts in the late myocardial infarction period and found that some cells had relatively normal resting potentials but depressed upstrokes that improved in the presence of verapamil or D-600. It is noteworthy that cells of normal papillary muscles that are partially depolarized by high extracellular potassium exhibit depressed fast sodium-dependent upstrokes that do not improve with verapamil.44 Ischemia 1392 causes greater depression of action potentials than that produced by similar levels of hyperkalemia in nonischemic tissue45 and it is likely that agents that affect the activation state of calcium channels modulate those factors that depress Vmax independent of membrane potential.
Although Vmax is not merely a reflection of sodium conductance, one could speculate that increased intracellular calcium affects the kinetics of the fast sodium channels either directly or indirectly by altering other factors such as intracellular pH.46"C alcium-channel activation or blockade also appears to affect determinants of conduction velocity not reflected in Vmax. As illustrated in figure 5, verapamil and Bay K 8644 shift the relationship of Vmax to 02 in opposite directions. At more depressed levels of Vma during ischemia, corresponding 02s are greater than control in the presence of verapamil and less than control in the presence of Bay K 8644. This further suggests that changes in conduction velocity cannot be accounted for entirely by changes in sodium conductance. In this regard, Buchanan et al. 25 have demonstrated in papillary muscle that interventions that primarily alter sodium conductance, including tetrodotoxin, type I antiarrhythmics, and changes in the sodium gradient, affect Vmax and conduction velocity as predicted by the relationship: Vmax a 02. In contrast, certain other interventions that affect conduction velocity, such as changes in extracellular calcium or pH, change the slope of this relationship. 48 Pressler et al. 41 have demonstrated that increasing extracellular calcium produces an increase in internal longitudinal resistance that is blocked by lanthanum but not by verapamil. They interpreted their findings as suggesting that this effect is mediated by calcium influx due to sodium/calcium exchange (rather than calcium influx via "slow channels"). However, verapamil has been demonstrated to attenuate the increase in internal longitudinal resistance produced by simulated ischemic conditions.49 This suggests that, during ischemia, additional factors may contribute to the increase in internal longitudinal resistance that can be affected by verapamil.
Calcium influx before and/or during ischemia might affect other electrophysiologic properties, such as membrane capacitance and threshold potential, by altering fixed surface changes.5 In nonischemic preparations, increased extracellular calcium has been shown to alter membrane resistance and capacitance in conjunction with changes in excitability. 4' In summary, the results of the present study confirm the previous findings of others that calcium-channel blockade attenuates ischemia-induced depression of action potentials and slowing of conduction. In addition, it was demonstrated that Bay K 8644, an agent that activates calcium channels, produces an exacerbation of these electrophysiologic effects of ischemia. These results are consistent with the hypothesis that these agents act by affecting calcium entry into myocardial cells. Analysis of the data suggests three separate components whereby the calcium-channel activation state can modulate the electrophysiologic response to ischemia: (1) small alterations in the magnitude of ischemia-induced depolarization of membrane potential that directly affect action potential upstroke velocity, (2) alterations in membrane responsiveness or the relation of VX. to resting membrane potential, and (3) alterations in factors that change the relationship of Vmax to 02, such as changes in excitability or cell-to-cell coupling.
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